Clinical factors | TCGA_BLCA | GSE13507 | GSE32548 | GSE32894 | ||||
---|---|---|---|---|---|---|---|---|
n = 403 | % | n = 165 | % | n = 130 | % | n = 224 | % | |
Age | ||||||||
≦ 60 | 107 | 26.55 | 46 | 27.88 | 27 | 20.77 | 46 | 20.54 |
> 60 | 296 | 73.45 | 119 | 72.12 | 103 | 79.23 | 178 | 79.46 |
Gender | ||||||||
Male | 298 | 73.95 | 135 | 81.82 | 99 | 76.15 | 163 | 72.77 |
Female | 105 | 26.05 | 30 | 18.18 | 31 | 23.85 | 61 | 27.23 |
T stage | ||||||||
< T2 | 4 | 0.99 | 104 | 63.03 | 91 | 70 | 173 | 77.23 |
≧ T2 | 366 | 94.29 | 61 | 36.97 | 38 | 29.23 | 51 | 22.77 |
Grade (WHO2004) | ||||||||
Low | 20 | 4.96 | 105 | 63.64 | – | – | – | – |
High | 380 | 94.29 | 60 | 36.36 | – | – | – | – |
Grade (WHO1999) | ||||||||
G1 | – | – | – | – | 15 | 11.54 | 45 | 20.09 |
G2 | – | – | – | – | 40 | 30.77 | 84 | 37.50 |
G3 | – | – | – | – | 75 | 57.69 | 93 | 41.52 |
Vital status | ||||||||
Alive | 248 | 61.54 | 96 | 58.18 | 105 | 80.77 | 199 | 88.84 |
Dead | 155 | 38.46 | 69 | 41.82 | 25 | 19.23 | 25 | 11.16 |
Follow-up (mean ± SD, year) | ||||||||
2.10 ± 2.23 | 3.98 ± 3.10 | 4.14 ± 2.38 | 3.28 ± 2.10 |